Cliff C. Cheng

428 total citations
13 papers, 304 citations indexed

About

Cliff C. Cheng is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Cliff C. Cheng has authored 13 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Cliff C. Cheng's work include Computational Drug Discovery Methods (3 papers), DNA Repair Mechanisms (2 papers) and Hepatitis B Virus Studies (2 papers). Cliff C. Cheng is often cited by papers focused on Computational Drug Discovery Methods (3 papers), DNA Repair Mechanisms (2 papers) and Hepatitis B Virus Studies (2 papers). Cliff C. Cheng collaborates with scholars based in United States, Australia and United Kingdom. Cliff C. Cheng's co-authors include Gerald W. Shipps, Xianshu Yang, Xiaohua Huang, Peter Orth, José S. Duca, Cheng‐Chi Chuang, Thierry Fischmann, Matthew Richards, Naim Nazef and Denise Murphy and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Lipid Research and Tetrahedron.

In The Last Decade

Cliff C. Cheng

12 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cliff C. Cheng United States	10	204	74	49	31	28	13	304
Hitoshi Sakashita Japan	10	220 1.1×	80 1.1×	54 1.1×	33 1.1×	18 0.6×	19	409
Mengxiao Shi United States	13	277 1.4×	173 2.3×	75 1.5×	42 1.4×	17 0.6×	20	536
Yuzhen Niu China	13	259 1.3×	45 0.6×	139 2.8×	17 0.5×	16 0.6×	24	442
Kai Gao China	6	193 0.9×	29 0.4×	31 0.6×	28 0.9×	18 0.6×	16	281
V.L. Linhard Germany	9	179 0.9×	21 0.3×	40 0.8×	25 0.8×	15 0.5×	17	283
Emma R. McKinney United States	6	197 1.0×	205 2.8×	23 0.5×	23 0.7×	17 0.6×	8	376
Xianshu Yang United States	9	264 1.3×	63 0.9×	52 1.1×	34 1.1×	18 0.6×	10	367
Katherine T. Barglow United States	7	360 1.8×	165 2.2×	27 0.6×	26 0.8×	45 1.6×	8	478
Arati Prabhu India	11	189 0.9×	108 1.5×	46 0.9×	25 0.8×	54 1.9×	28	318
Orrette R. Wauchope United States	13	259 1.3×	106 1.4×	16 0.3×	30 1.0×	7 0.3×	20	447

Countries citing papers authored by Cliff C. Cheng

Since Specialization

Citations

This map shows the geographic impact of Cliff C. Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cliff C. Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cliff C. Cheng more than expected).

Fields of papers citing papers by Cliff C. Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cliff C. Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cliff C. Cheng. The network helps show where Cliff C. Cheng may publish in the future.

Co-authorship network of co-authors of Cliff C. Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Cliff C. Cheng. A scholar is included among the top collaborators of Cliff C. Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cliff C. Cheng. Cliff C. Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Liu, Bing, Kang Ning, Fang Yang, et al.. (2025). Discovery of FLT3-ITD Inhibitor Clifutinib: A Novel Biphenylacetylene Urea Derivative in Clinical Trials for the Treatment of Relapsed/Refractory FLT3-ITD⁺ Acute Myeloid Leukemia. Journal of Medicinal Chemistry. 68(8). 7955–7972. 5 indexed citations

Huang, Xiaohua, Cliff C. Cheng, Thierry Fischmann, et al.. (2013). Structure-based design and optimization of 2-aminothiazole-4-carboxamide as a new class of CHK1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(9). 2590–2594. 26 indexed citations

Whitehurst, Charles E., Zhiping Yao, Denise Murphy, et al.. (2012). Application of Affinity Selection-Mass Spectrometry Assays to Purification and Affinity-Based Screening of the Chemokine Receptor CXCR4. Combinatorial Chemistry & High Throughput Screening. 15(6). 473–485. 14 indexed citations

Huang, Xiaohua, Cliff C. Cheng, Thierry Fischmann, et al.. (2012). Discovery of a Novel Series of CHK1 Kinase Inhibitors with a Distinctive Hinge Binding Mode. ACS Medicinal Chemistry Letters. 3(2). 123–128. 30 indexed citations

Hong, Lan, Cliff C. Cheng, Timothy J. Kowalski, et al.. (2011). Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity. Journal of Lipid Research. 52(4). 646–656. 72 indexed citations

Huang, Xiaohua, Gerald W. Shipps, Cliff C. Cheng, et al.. (2011). Discovery and Hit-to-Lead Optimization of Non-ATP Competitive MK2 (MAPKAPK2) Inhibitors. ACS Medicinal Chemistry Letters. 2(8). 632–637. 26 indexed citations

Cheng, Cliff C., Gerald W. Shipps, Zhiwei Yang, et al.. (2010). Inhibitors of hepatitis C virus polymerase: Synthesis and characterization of novel 2-oxy-6-fluoro-N-((S)-1-hydroxy-3-phenylpropan-2-yl)-benzamides. Bioorganic & Medicinal Chemistry Letters. 20(7). 2119–2124. 20 indexed citations

Roy, Sudipta Raha, et al.. (2010). Direct synthesis of Cbz-protected (2-amino)-6-(2-aminoethyl)pyridines. Tetrahedron. 66(11). 1973–1979. 6 indexed citations

Cheng, Cliff C., Xiaohua Huang, Gerald W. Shipps, et al.. (2010). Pyridine Carboxamides: Potent Palm Site Inhibitors of HCV NS5B Polymerase. ACS Medicinal Chemistry Letters. 1(9). 466–471. 16 indexed citations

10.

Cheng, Cliff C., Gerald W. Shipps, Zhiwei Yang, et al.. (2009). Discovery and optimization of antibacterial AccC inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(23). 6507–6514. 40 indexed citations

11.

Annis, Douglas S., Cliff C. Cheng, Cheng‐Chi Chuang, et al.. (2009). Inhibitors of the Lipid Phosphatase SHIP2 Discovered by High Throughput Affinity Selection-Mass Spectrometry Screening of Combinatorial Libraries. Combinatorial Chemistry & High Throughput Screening. 12(8). 760–771. 24 indexed citations

12.

Whitehurst, Charles E., Naim Nazef, D. Allen Annis, et al.. (2006). Discovery and Characterization of Orthosteric and Allosteric Muscarinic M2 Acetylcholine Receptor Ligands by Affinity Selection–Mass Spectrometry. SLAS DISCOVERY. 11(2). 194–207. 24 indexed citations

13.

Cheng, Cliff C. & Robert F. Dennehy. (1996). Terse Organizational Storytelling at its Best. Journal of Management Inquiry. 5(3). 207–213. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact